|
US3311628A
(en)
*
|
1965-03-09 |
1967-03-28 |
Bristol Myers Co |
Derivatives of pyrrolo [2, 3-d] pyrimidine
|
|
CH592668A5
(pm)
*
|
1973-10-02 |
1977-10-31 |
Delalande Sa |
|
|
ATE159257T1
(de)
*
|
1994-05-03 |
1997-11-15 |
Ciba Geigy Ag |
Pyrrolopyrimidinderivate mit antiproliferativer wirkung
|
|
BR9911612A
(pt)
*
|
1998-06-02 |
2001-02-06 |
Osi Pharm Inc |
Composições de pirrolo[2,3d]pirimidina e seus usos
|
|
US6686366B1
(en)
|
1998-06-02 |
2004-02-03 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A3 receptor and uses thereof
|
|
US6878716B1
(en)
|
1998-06-02 |
2005-04-12 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 receptor and uses thereof
|
|
ATE265458T1
(de)
*
|
1998-06-19 |
2004-05-15 |
Pfizer Prod Inc |
Pyrrolo(2,3-d)pyrimidin-verbindungen
|
|
PA8474101A1
(es)
|
1998-06-19 |
2000-09-29 |
Pfizer Prod Inc |
Compuestos de pirrolo [2,3-d] pirimidina
|
|
US7160890B2
(en)
|
1999-12-02 |
2007-01-09 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A3 receptor and uses thereof
|
|
US6680322B2
(en)
|
1999-12-02 |
2004-01-20 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 receptors and uses thereof
|
|
US6664252B2
(en)
|
1999-12-02 |
2003-12-16 |
Osi Pharmaceuticals, Inc. |
4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
|
|
HRP20020509B1
(en)
|
1999-12-10 |
2005-06-30 |
Pfizer Products Inc. |
PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS
|
|
US6680324B2
(en)
|
2000-12-01 |
2004-01-20 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A1 receptors and uses thereof
|
|
US6673802B2
(en)
|
2000-12-01 |
2004-01-06 |
Osi Pharmaceuticals, Inc. |
Compounds specific to adenosine A3 receptor and uses thereof
|
|
DE10148883A1
(de)
*
|
2001-10-04 |
2003-04-10 |
Merck Patent Gmbh |
Pyrimidinderivate
|
|
AU2002360436A1
(en)
|
2001-11-30 |
2003-06-17 |
Osi Pharmaceuticals, Inc. |
2-aryl pyrrologpyrimidines for a1 and a3 receptors
|
|
EA011809B1
(ru)
|
2001-12-20 |
2009-06-30 |
Оси Фармасьютикалз, Инк. |
Пиримидиновые соединения, их применение в качестве a-селективных антагонистов и способ их получения
|
|
CN101973998A
(zh)
|
2001-12-20 |
2011-02-16 |
Osi药物公司 |
吡咯并嘧啶A2b选择性拮抗剂化合物
|
|
BR0316487A
(pt)
|
2002-11-26 |
2005-10-11 |
Pfizer Prod Inc |
Método todo de tratamento da rejeição de transplantes
|
|
TW200738709A
(en)
*
|
2006-01-19 |
2007-10-16 |
Osi Pharm Inc |
Fused heterobicyclic kinase inhibitors
|
|
CN102131812B
(zh)
|
2008-08-20 |
2014-04-09 |
硕腾有限责任公司 |
吡咯并[2，3-d]嘧啶化合物
|
|
NL2022471B1
(en)
|
2019-01-29 |
2020-08-18 |
Vationpharma B V |
Solid state forms of oclacitinib
|